期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
The influence of OCT1 gene polymorphisms on the metformin response in Uygur patients with glucose metabolism disorder
1
作者 WANG Tao YI Tao-cun +11 位作者 WANG Ye WANG Zhi-hong WANH Chang-hui MAO Xin-min RAN Xin-jian HU Meng-yin GE Wen-ning ZHANG Min-fang XIE Zi-jing LI Shi-qiang LAN Yi LI Lin-lin 《新疆医科大学学报》 CAS 2010年第10期1175-1180,共6页
Objective To determine the effects of genetic variation in the organic cation transporter 1(OCT1)on the short-term responses of the antidiabetic drug,metformin.Method A total of 22 patients recruited with type 2 diabe... Objective To determine the effects of genetic variation in the organic cation transporter 1(OCT1)on the short-term responses of the antidiabetic drug,metformin.Method A total of 22 patients recruited with type 2 diabetes or IFG were treated with metformin(2 000 mg/day)for 1 week.The patients were screened from Second Jikun hospital and Kashidonglu community medicine service,Urumqi,China and their surrounding districts.To examine the effects of metformin on plasma glucose,total cholesterol,low-density lipoprotein-cholesterol,high-density lipoprotein-cholesterol and triglyceride in relation with R61C,G465R and 420 del variants of OCT1(gene encoding organic cation transporter 1,mainly locating in liver,which is metformin's major target)in subjects.In all,R61C,G465R and 420del of OCT1 gene were examined using DNA extracted from whole blood and PCR-RFLP.Data concerning with gene and metformin treatment were handled by t-test.Result After metformin treatment,there were increases both in FPG and LDL(P=0.011and P=0.013 respectively).To divide all participants into mutant and wild groups,according to the polymorphisms of R61C,G465R and 420 del respectively,as well as carriers with one of the mutant genotypes at least and carriers with none of the mutant sites.Analysis was made to compared FPG,Chol,TG,and LDL and HDL between carriers of wild genotypes and carriers of other genotypes showed no statistic significance both before the metformin treatment and after the treatment.The same is the case with changes of FPG,Chol,TG,and LDL and HDL of wild genotype carriers and variant genotype carriers,except of LDL changes(P=0.05)in patients grouped by G465R polymorphisms and TG changes(P=0.03)in subjects differed by 420del genotypes.Conclusion In this study,it is suggested that OCT1 gene polymorphisms have little contribution to the clinical efficacy of blood glucose control by metformin among Uygur people with type 2 diabetes or IFG,but it may have possible relationship with the clinical efficacy on fat metabolism by metformin. 展开更多
关键词 OCT1基因 基因治疗 疗效
下载PDF
Relationship between polymorphisms of ABCB1 gene and epilepsy in Uygur population of Xinjiang region
2
作者 Hua Gao Jie-Ping Mao +1 位作者 Dang Wang Xin-Ling Yang 《Journal of Hainan Medical University》 2019年第12期24-27,共4页
Objective:To study the association of ABCB1 gene with epilepsy in the Uygur population of Xinjiang region.Methods: In this case-control study, 232 confirmed epilepsy patients from Xinjiang affiliated Medical Universit... Objective:To study the association of ABCB1 gene with epilepsy in the Uygur population of Xinjiang region.Methods: In this case-control study, 232 confirmed epilepsy patients from Xinjiang affiliated Medical University from January 2017 to June 2018, and 116 were recruited in the case group and 116 healthy individuals were selected as the control group. 2 mL of the blood sample was collected from each subject, from which the DNA was extracted. The polymorphism gene was determined by polymerase chain reaction followed by restriction fragment length polymorphism.Results: No significant association was observed in C3435T alleles and genotypes with epilepsy between the case and the control groups (P>0.05), G2677T/A genotypes with epilepsy was the same as GG in both of the groups.Conclusions:The polymorphisms of C3435T gene may not be associated with epilepsy in the Uygur population from the Xinjiang region. 展开更多
关键词 EPILEPSY POLYMORPHISMS ABCB1 gene UYGUR PEOPLE
下载PDF
Clinical characteristics of early and late drug-eluting stent in-stent restenosis and mid-term prognosis after repeated percutaneous coronary intervention 被引量:5
3
作者 Jian-Feng Zheng Ting-Ting Guo +13 位作者 Yuan Tian Yong Wang Xiao-Ying Hu Yue Chang Hong Qiu Ke-Fei Dou Yi-Da Tang Jin-Qing Yuan Yong-Jian Wu Hong-Bing Yan Shu-Bin Qiao Bo Xu Yue-Jin Yang Run-Lin Gao 《Chinese Medical Journal》 SCIE CAS CSCD 2020年第22期2674-2681,共8页
Background:The mechanism and characteristics of early and late drug-eluting stent in-stent restenosis(DES-ISR)have not been fully clarified.Whether there are different outcomes among those patients being irrespective ... Background:The mechanism and characteristics of early and late drug-eluting stent in-stent restenosis(DES-ISR)have not been fully clarified.Whether there are different outcomes among those patients being irrespective of their repeated treatments remain a knowledge gap.Methods:A total of 250 patients who underwent initial stent implantation in our hospital,and then were readmitted to receive treatment for the reason of recurrent significant DES-ISR in 2016 were involved.The patients were categorized as early ISR(<12 months;E-ISR;n=32)and late ISR(≥12 months;L-ISR;n=218).Associations between patient characteristics and clinical performance,as well as clinical outcomes after a repeated percutaneous coronary intervention(PCI)were evaluated.Primary composite endpoint of major adverse cardiac events(MACEs)included cardiac death,non-fatal myocardial infarction(MI),or target lesion revascularization(TLR).Results:Most baseline characteristics are similar in both groups,except for the period of ISR,initial pre-procedure thrombolysis in myocardial infarction,and some serum biochemical indicators.The incidence of MACE(37.5%vs.5.5%;P<0.001)and TLR(37.5%vs.5.0%;P<0.001)is higher in the E-ISR group.After multivariate analysis,E-ISR(odds ratio[OR],13.267;[95%CI 4.984-35.311];P<0.001)and left ventricular systolic dysfunction(odds ratio[OR],6.317;[95%CI 1.145-34.843];P=0.034)are the independent predictors for MACE among DES-ISR patients in the mid-term follow-up of 12 months.Conclusions:Early ISR and left ventricular systolic dysfunction are associated with MACE during the mid-term follow-up period for DES-ISR patients.The results may benefit the risk stratification and secondary prevention for DES-ISR patients in clinical practice. 展开更多
关键词 In-stent restenosis Neointimal hyperplasia Risk factors Drug-eluting stent
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部